24-norursodeoxycholic acid has been researched along with Cholangitis, Sclerosing in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altorjay, I; Bergquist, A; Chapman, R; Denk, G; Färkkilä, M; Fickert, P; Greinwald, R; Halilbasic, E; Hirschfield, GM; Manns, MP; Marschall, HU; Nevens, F; Pröls, M; Reiter, FP; Schramm, C; Schrumpf, E; Spengler, U; Tornai, I; Trauner, M; Trivedi, P | 1 |
| Chazouillères, O | 1 |
| Halilbasic, E; Hofer, H; Kazemi-Shirazi, L; Kienbacher, C; Staufer, K; Trauner, M; Traussnigg, S | 1 |
| Fuchs, C; Halilbasic, E; Hofer, H; Paumgartner, G; Trauner, M | 1 |
| Alpini, G; Glaser, SS | 1 |
| Lankisch, TO; Weismüller, TJ | 1 |
| Cover, C; Denk, H; Fickert, P; Fuchsbichler, A; Hofmann, AF; Jaeschke, H; Liu, J; Marschall, HU; Trauner, M; Tsybrovskyy, O; Waalkes, MP; Wagner, M; Zatloukal, K; Zollner, G | 1 |
3 review(s) available for 24-norursodeoxycholic acid and Cholangitis, Sclerosing
| Article | Year |
|---|---|
Therapeutic role of bile acids and nuclear receptor agonists in fibrosing cholangiopathies.
Topics: Bile Acids and Salts; Cholangitis, Sclerosing; Humans; Ligands; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2014 |
Therapy of Primary Sclerosing Cholangitis--Today and Tomorrow.
Topics: Cholagogues and Choleretics; Cholangitis, Sclerosing; Gastrointestinal Microbiome; Humans; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2015 |
Medical and endoscopic therapy of primary sclerosing cholangitis.
Topics: Anti-Bacterial Agents; Catheterization; Cholagogues and Choleretics; Cholangitis, Sclerosing; Endoscopy, Digestive System; Humans; Immunosuppressive Agents; Stents; Ursodeoxycholic Acid | 2011 |
1 trial(s) available for 24-norursodeoxycholic acid and Cholangitis, Sclerosing
| Article | Year |
|---|---|
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis.
Topics: Adult; Alkaline Phosphatase; Cholangitis, Sclerosing; Cholestasis; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Ursodeoxycholic Acid | 2017 |
3 other study(ies) available for 24-norursodeoxycholic acid and Cholangitis, Sclerosing
| Article | Year |
|---|---|
24-Norursodeoxycholic acid in patients with primary sclerosing cholangitis: A new "urso saga" on the horizon?
Topics: Cholangitis, Sclerosing; Cholestasis; Humans; Ursodeoxycholic Acid | 2017 |
Activation of the cholehepatic shunt as a potential therapy for primary sclerosing cholangitis.
Topics: Animals; Bile Ducts; Cholangitis, Sclerosing; Epithelial Cells; Hepatocytes; Humans; Ursodeoxycholic Acid | 2009 |
24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Bile Acids and Salts; Cholangitis, Sclerosing; Disease Models, Animal; Mice; Mice, Knockout; Ursodeoxycholic Acid | 2006 |